Contact
searchSearch
HMP Global

Atopic Dermatitis Excellence Forum

Baldwin
Videos
The Skin Microbiome: Dermatologic Insights
05/22/2026
Hilary E. Baldwin, MD; Riya Gandhi, MA
Dr Hilary Baldwin discusses how evolving insights into the skin microbiome are reshaping the understanding of acne, eczema, rosacea, and other inflammatory skin diseases.
Dr Hilary Baldwin discusses how evolving insights into the skin microbiome are reshaping the understanding of acne, eczema, rosacea, and other inflammatory skin diseases.
Dr Hilary Baldwin discusses how...
05/22/2026
The Dermatologist
NEA Approved Features
Closing Gaps in Eczema Research
05/21/2026
Coleen Stern, MA
New research will explore key aspects of eczema, from the science and genetics behind inflammation to advanced screening and patient-reported outcomes.
New research will explore key aspects of eczema, from the science and genetics behind inflammation to advanced screening and patient-reported outcomes.
New research will explore key...
05/21/2026
The Dermatologist
NEA Approved Features
Supporting the Transition to Self-Managed Care in Adolescents and Young Adults With Atopic Dermatitis
03/09/2026
Allison Loiselle, PhD; Jessica Garlewicz
The National Eczema Association offers practical guidance on assessing transition readiness and empowering adolescents and young adults as they move toward independent atopic dermatitis care.
The National Eczema Association offers practical guidance on assessing transition readiness and empowering adolescents and young adults as they move toward independent atopic dermatitis care.
The National Eczema Association...
03/09/2026
The Dermatologist
Dr Guttman
Conference Coverage
Atopic Dermatitis: OX40, IL-31, Treg Therapy, and the JAK Head-to-Head Era
02/21/2026
Riya Gandhi, MA
A dermatology update on atopic dermatitis therapeutics, highlighting dupilumab, lebrikizumab, nemolizumab, rocatinlimab (OX40), amlitelimab (OX40L), rezpegaldesleukin, and oral JAK inhibitors (upadacitinib, abrocitinib).
A dermatology update on atopic dermatitis therapeutics, highlighting dupilumab, lebrikizumab, nemolizumab, rocatinlimab (OX40), amlitelimab (OX40L), rezpegaldesleukin, and oral JAK inhibitors (upadacitinib, abrocitinib).
A dermatology update on atopic...
02/21/2026
The Dermatologist
Dr Guttman
Conference Coverage
Chronic Hand Eczema: From Pathogenic Subtypes to Targeted JAK and IL-4/13 Therapy
02/20/2026
Riya Gandhi, MA
A clinical update on chronic hand eczema, highlighting delgocitinib cream, ruxolitinib, gusacitinib, dupilumab, tralokinumab, and biomarker-driven Th1/Th2/Th17 endotypes.
A clinical update on chronic hand eczema, highlighting delgocitinib cream, ruxolitinib, gusacitinib, dupilumab, tralokinumab, and biomarker-driven Th1/Th2/Th17 endotypes.
A clinical update on chronic...
02/20/2026
The Dermatologist
NEA Approved Features
Patient Self-Monitoring and Shared Decision-Making in Atopic Dermatitis
12/09/2025
Jessica Garlewicz
As eczema care continues to progress toward different treat-to-target and other shared treatment goals with patients, self-monitoring can be integral to support this evolving care framework.
As eczema care continues to progress toward different treat-to-target and other shared treatment goals with patients, self-monitoring can be integral to support this evolving care framework.
As eczema care continues to...
12/09/2025
The Dermatologist
Mona Shahriari, MD, FAAD
Conference Coverage
Clarifying the Role of IL-13 Inhibitors in Atopic Dermatitis: Clinical Profiles, Comparisons, and Real-World Application
11/26/2025
Jessica Garlewicz
The session emphasized mechanism-driven selection, real-world application, and a comparison of pivotal efficacy data for the 3 IL-13–related biologics currently available: dupilumab, lebrikizumab, and tralokinumab.
The session emphasized mechanism-driven selection, real-world application, and a comparison of pivotal efficacy data for the 3 IL-13–related biologics currently available: dupilumab, lebrikizumab, and tralokinumab.
The session emphasized...
11/26/2025
The Dermatologist
Linda F. Stein Gold, MD
Conference Coverage
Charting a Path to Higher Treatment Targets With JAK Inhibition in Atopic Dermatitis
11/01/2025
Jessica Garlewicz
The session focused on elevating therapeutic expectations in AD care, analyzing data on existing JAK inhibitors, and encouraging dermatologists to challenge treatment inertia.
The session focused on elevating therapeutic expectations in AD care, analyzing data on existing JAK inhibitors, and encouraging dermatologists to challenge treatment inertia.
The session focused on elevating...
11/01/2025
The Dermatologist
Cover Story
Chronic Hand Eczema: Breaking Out of the Atopic Dermatitis Umbrella
10/06/2025
Jeff Yu, MD
This condition may be far more common and burdensome than previously recognized in US dermatologic practice.
This condition may be far more common and burdensome than previously recognized in US dermatologic practice.
This condition may be far more...
10/06/2025
The Dermatologist
Physician and older couple
Quiz
Which Systemic Therapy Raises Red Flags in Older Adults?
09/18/2025
Riya Gandhi, MA
Older patients need special consideration. Take the quiz to identify which systemic drug class carries higher risks—like thrombosis and malignancy—and requires extra caution in aging populations.
Older patients need special consideration. Take the quiz to identify which systemic drug class carries higher risks—like thrombosis and malignancy—and requires extra caution in aging populations.
Older patients need special...
09/18/2025
The Dermatologist
Katrina Abuabara
Videos
Systemic Treatments for Special Populations in Dermatology
09/10/2025
Katrina Abuabara, MD, MA, MSCE
Dr Katrina Abuabara shares strategies for safely prescribing systemic therapies in special populations with atopic dermatitis—covering pregnancy, older adults, comorbidities, drug interactions, and real-world data limitations.
Dr Katrina Abuabara shares strategies for safely prescribing systemic therapies in special populations with atopic dermatitis—covering pregnancy, older adults, comorbidities, drug interactions, and real-world data limitations.
Dr Katrina Abuabara shares...
09/10/2025
The Dermatologist

Multimedia

Baldwin
Videos
The Skin Microbiome: Dermatologic Insights
05/22/2026
Hilary E. Baldwin, MD; Riya Gandhi, MA
Dr Hilary Baldwin discusses how evolving insights into the skin microbiome are reshaping the understanding of acne, eczema, rosacea, and other inflammatory skin diseases.
Dr Hilary Baldwin discusses how evolving insights into the skin microbiome are reshaping the understanding of acne, eczema, rosacea, and other inflammatory skin diseases.
Dr Hilary Baldwin discusses how...
05/22/2026
The Dermatologist
Katrina Abuabara
Videos
Systemic Treatments for Special Populations in Dermatology
09/10/2025
Katrina Abuabara, MD, MA, MSCE
Dr Katrina Abuabara shares strategies for safely prescribing systemic therapies in special populations with atopic dermatitis—covering pregnancy, older adults, comorbidities, drug interactions, and real-world data limitations.
Dr Katrina Abuabara shares strategies for safely prescribing systemic therapies in special populations with atopic dermatitis—covering pregnancy, older adults, comorbidities, drug interactions, and real-world data limitations.
Dr Katrina Abuabara shares...
09/10/2025
The Dermatologist
James Song
Videos
JAK Inhibitors in Treating Atopic Dermatitis
12/02/2024
Eingun James Song, MD, FAAD
In this interview, Dr Song explains the unique mechanisms of JAK inhibitors compared to traditional immunosuppressants in atopic dermatitis treatment.
In this interview, Dr Song explains the unique mechanisms of JAK inhibitors compared to traditional immunosuppressants in atopic dermatitis treatment.
In this interview, Dr Song...
12/02/2024
The Dermatologist
Lawrence F. Eichenfield, MD, FAAD
Videos
Topical Medications in Atopic Dermatitis: Updates and Insights from Latest Guidelines
04/04/2024
Lawrence F. Eichenfield, MD, FAAD
In this interview, Dr Eichenfield outlines key recommendations and updates from the latest guidelines for managing atopic dermatitis with topical medications.
In this interview, Dr Eichenfield outlines key recommendations and updates from the latest guidelines for managing atopic dermatitis with topical medications.
In this interview, Dr...
04/04/2024
The Dermatologist
Dr Jonathan Silverberg
Videos
Insights From Spring AAD 2024: Atopic Dermatitis in Adults
03/19/2024
Jonathan Silverberg, MD
In this feature video, Dr Jonathan Silverberg went over what his session covered prior to Spring AAD 2024.
In this feature video, Dr Jonathan Silverberg went over what his session covered prior to Spring AAD 2024.
In this feature video, Dr...
03/19/2024
The Dermatologist
stein gold
Videos
Non-Steroidal Topical Therapies: Changing Psoriasis and Atopic Dermatitis Treatment
02/20/2024
Linda Stein Gold, MD
In this interview, Dr Linda Stein Gold shares her presentation at the 2023 Fall Clinical Conference on the influence of non-steroidal topical therapies on psoriasis and atopic dermatitis.
In this interview, Dr Linda Stein Gold shares her presentation at the 2023 Fall Clinical Conference on the influence of non-steroidal topical therapies on psoriasis and atopic dermatitis.
In this interview, Dr Linda...
02/20/2024
The Dermatologist
Dr Ilka Netravali
Videos
Initiation of Dupilumab For Severe Atopic Dermatitis and Rapid Resolution of Diffuse Warts
01/15/2024
Arun Netravali, MD, PhD, FAAD
In this feature video, Dr Ilka Netravali shared insights from her study on diffuse warts following initiation of dupilumab for severe atopic dermatitis.
In this feature video, Dr Ilka Netravali shared insights from her study on diffuse warts following initiation of dupilumab for severe atopic dermatitis.
In this feature video, Dr Ilka...
01/15/2024
The Dermatologist
Emma Guttman
Videos
Alopecia Areata: Navigating its Connections with Atopic Dermatitis
01/05/2024
Emma Guttman-Yassky, MD, PhD
In this interview, Dr Guttman-Yassky delves into the intricate landscape of alopecia areata, unraveling its diverse phenotypes, drawing parallels with atopic dermatitis, and providing valuable guidance for clinicians navigating the challenges...
In this interview, Dr Guttman-Yassky delves into the intricate landscape of alopecia areata, unraveling its diverse phenotypes, drawing parallels with atopic dermatitis, and providing valuable guidance for clinicians navigating the challenges...
In this interview, Dr...
01/05/2024
The Dermatologist
Jonathan Silverberg, MD, PhD, MPH
Q&As
Revolutionizing Atopic Dermatitis: Virtual Sessions on Optimizing Patient Care
12/13/2023
Jessica Garlewicz
Dr Jonathan Silverberg discussed how he hoped physicians gained a better understanding of the latest research and approaches when treating atopic dermatitis during the Revolutionizing Atopic Dermatitis virtual session.
Dr Jonathan Silverberg discussed how he hoped physicians gained a better understanding of the latest research and approaches when treating atopic dermatitis during the Revolutionizing Atopic Dermatitis virtual session.
Dr Jonathan Silverberg discussed...
12/13/2023
The Dermatologist
Joslyn Sciacca Kirby
Videos
Insights From Fall Clinical: Using OTC Products
11/15/2023
Joslyn R. Sciacca Kirby, MD
In this feature video, Dr Kirby shares her presentation at the 2023 Fall Clinical Conference on leveraging OTC products in her practice.
In this feature video, Dr Kirby shares her presentation at the 2023 Fall Clinical Conference on leveraging OTC products in her practice.
In this feature video, Dr Kirby...
11/15/2023
The Dermatologist
Dr Lisa Swanson
Videos
Pediatric Atopic Dermatitis: Diagnosis, Treatment Selection, and Long-Term Health Considerations
11/03/2026
Elizabeth Swanson, MD; Jessica Garlewicz
Lisa Swanson, MD, emphasizes the importance of early, effective treatment of pediatric atopic dermatitis, highlighting emerging evidence that dupilumab may improve growth and bone health outcomes while potentially reducing the risk of atopic...
Lisa Swanson, MD, emphasizes the importance of early, effective treatment of pediatric atopic dermatitis, highlighting emerging evidence that dupilumab may improve growth and bone health outcomes while potentially reducing the risk of atopic...
Lisa Swanson, MD, emphasizes the...
11/03/2026
The Dermatologist
KOL Roundtable
Videos
Type 2 Inflammation as an Underlying Disease Driver
11/02/2026
Raj Chovatiya, MD, PhD; Tina Bhutani, MD, MAS; Daniel C. Butler, MD; Jason Ezra Hawkes, MD, MS, FAAD
Dr Raj Chovatiya moderates an expert roundtable with Drs Tina Bhutani, Daniel Butler, and Jason Hawkes, exploring how type 2 inflammation drives chronic inflammatory skin diseases, including atopic dermatitis, prurigo nodularis, and chronic...
Dr Raj Chovatiya moderates an expert roundtable with Drs Tina Bhutani, Daniel Butler, and Jason Hawkes, exploring how type 2 inflammation drives chronic inflammatory skin diseases, including atopic dermatitis, prurigo nodularis, and chronic...
Dr Raj Chovatiya moderates an...
11/02/2026
The Dermatologist
Brian Kim
Videos
From Cytokines to Clinic: Translating Type 2 Biology Into Prurigo Nodularis Treatment
11/01/2026
Brian Kim, MD, MTR, FAAD; Riya Gandhi, MA
Dr Brian Kim explores how IL-4 and IL-13 drive itch, fibrosis, and nodule formation in prurigo nodularis through neuroimmune and type 2 inflammatory pathways.
Dr Brian Kim explores how IL-4 and IL-13 drive itch, fibrosis, and nodule formation in prurigo nodularis through neuroimmune and type 2 inflammatory pathways.
Dr Brian Kim explores how IL-4...
11/01/2026
The Dermatologist
Goldberg
Videos
Image-Guided SRT for Nonmelanoma Skin Cancer
10/16/2026
David Goldberg, MD, JD; Riya Gandhi, MA
Dr David Goldberg discusses how high-resolution ultrasound guidance is improving superficial radiation therapy for nonmelanoma skin cancers.
Dr David Goldberg discusses how high-resolution ultrasound guidance is improving superficial radiation therapy for nonmelanoma skin cancers.
Dr David Goldberg discusses how...
10/16/2026
The Dermatologist
Dr Martina Porter
Videos
Expert Insights: Povorcitinib for Hidradenitis Suppurativa
10/15/2026
Martina Porter, MD; Jessica Garlewicz
Povorcitinib improved HiSCR50 responses in moderate-to-severe hidradenitis suppurativa, with higher dosing potentially benefiting patients with more severe disease and a generally favorable safety profile through 54 weeks.
Povorcitinib improved HiSCR50 responses in moderate-to-severe hidradenitis suppurativa, with higher dosing potentially benefiting patients with more severe disease and a generally favorable safety profile through 54 weeks.
Povorcitinib improved HiSCR50...
10/15/2026
The Dermatologist
Dr Lisa Swanson
Videos
Biologic Decision-Making for Moderate-to-Severe Atopic Dermatitis
10/15/2026
Jessica Garlewicz; Elizabeth Swanson, MD
Individualized management of moderate-to-severe atopic dermatitis should consider overall disease burden, patient-specific factors and preferences, and clear treatment expectations to guide systemic therapy selection and support adherence.
Individualized management of moderate-to-severe atopic dermatitis should consider overall disease burden, patient-specific factors and preferences, and clear treatment expectations to guide systemic therapy selection and support adherence.
Individualized management of...
10/15/2026
The Dermatologist
Dr Raj Chovatiya
Videos
Optimizing Biologic Treatment Decisions in Moderate-to-Severe Atopic Dermatitis
10/15/2026
Raj Chovatiya, MD, PhD; Jessica Garlewicz
Raj Chovatiya, MD, PhD, emphasizes individualized biologic selection, shared decision-making, and adequate treatment optimization before switching therapies in patients with moderate-to-severe atopic dermatitis.
Raj Chovatiya, MD, PhD, emphasizes individualized biologic selection, shared decision-making, and adequate treatment optimization before switching therapies in patients with moderate-to-severe atopic dermatitis.
Raj Chovatiya, MD, PhD,...
10/15/2026
The Dermatologist
cohen
Videos
Targeting Type 2 Inflammation in Eczema, Prurigo Nodularis, and Urticaria
10/01/2026
Jeffrey M. Cohen, MD; Riya Gandhi, MA
Dr Jeffrey Cohen discusses how IL-4, IL-13, and IL-31 drive inflammation and itch across eczema, prurigo nodularis, and chronic urticaria.
Dr Jeffrey Cohen discusses how IL-4, IL-13, and IL-31 drive inflammation and itch across eczema, prurigo nodularis, and chronic urticaria.
Dr Jeffrey Cohen discusses how...
10/01/2026
The Dermatologist
Goldberg
Videos
Prolactin Receptor Inhibition for Hair Loss: A New Frontier in Hair Regrowth
09/28/2026
David Goldberg, MD, JD; Riya Gandhi, MA
Dr David Goldberg discusses emerging prolactin receptor–targeted therapies for androgenetic alopecia and other hair disorders.
Dr David Goldberg discusses emerging prolactin receptor–targeted therapies for androgenetic alopecia and other hair disorders.
Dr David Goldberg discusses...
09/28/2026
The Dermatologist
Bloom
Videos
Biostimulatory Fillers in Facial Rejuvenation
09/28/2026
Jason Bloom, MD, FACS; Riya Gandhi, MA
Dr Jason Bloom discusses the evolution of facial rejuvenation from line-filling to comprehensive facial balancing through volumization and biostimulation.
Dr Jason Bloom discusses the evolution of facial rejuvenation from line-filling to comprehensive facial balancing through volumization and biostimulation.
Dr Jason Bloom discusses the...
09/28/2026
The Dermatologist

From the Journal

NEA Approved Features
Closing Gaps in Eczema Research
05/21/2026
Coleen Stern, MA
New research will explore key aspects of eczema, from the science and genetics behind inflammation to advanced screening and patient-reported outcomes.
New research will explore key aspects of eczema, from the science and genetics behind inflammation to advanced screening and patient-reported outcomes.
New research will explore key...
05/21/2026
The Dermatologist
NEA Approved Features
Supporting the Transition to Self-Managed Care in Adolescents and Young Adults With Atopic Dermatitis
03/09/2026
Allison Loiselle, PhD; Jessica Garlewicz
The National Eczema Association offers practical guidance on assessing transition readiness and empowering adolescents and young adults as they move toward independent atopic dermatitis care.
The National Eczema Association offers practical guidance on assessing transition readiness and empowering adolescents and young adults as they move toward independent atopic dermatitis care.
The National Eczema Association...
03/09/2026
The Dermatologist
NEA Approved Features
Patient Self-Monitoring and Shared Decision-Making in Atopic Dermatitis
12/09/2025
Jessica Garlewicz
As eczema care continues to progress toward different treat-to-target and other shared treatment goals with patients, self-monitoring can be integral to support this evolving care framework.
As eczema care continues to progress toward different treat-to-target and other shared treatment goals with patients, self-monitoring can be integral to support this evolving care framework.
As eczema care continues to...
12/09/2025
The Dermatologist
Cover Story
Chronic Hand Eczema: Breaking Out of the Atopic Dermatitis Umbrella
10/06/2025
Jeff Yu, MD
This condition may be far more common and burdensome than previously recognized in US dermatologic practice.
This condition may be far more common and burdensome than previously recognized in US dermatologic practice.
This condition may be far more...
10/06/2025
The Dermatologist
NEA Approved Features
Eczema Action Plans: Personalized Tools for Empowering Patients and Enhancing Care
09/08/2025
Jessica Garlewicz
National Eczema Association researchers offer practical guidance grounded in real-world patient and provider needs to optimize long-term atopic dermatitis control and better support patient self-management.
National Eczema Association researchers offer practical guidance grounded in real-world patient and provider needs to optimize long-term atopic dermatitis control and better support patient self-management.
National Eczema Association...
09/08/2025
The Dermatologist
NEA Approved Features
Eczema in the United States: Insights from a National Study on Prevalence and Co-Occurrence
06/05/2025
Lisa Kuhs, PhD
The All of Us database highlights the complexity of eczema beyond atopic dermatitis and emphasizes the need for a more nuanced approach in both clinical practice and research.
The All of Us database highlights the complexity of eczema beyond atopic dermatitis and emphasizes the need for a more nuanced approach in both clinical practice and research.
The All of Us database...
06/05/2025
The Dermatologist
Cover Story
Advancing Itch Management With Emerging Therapies and Neuromodulation
05/01/2025
Brian Kim, MD, MTR, FAAD
Dr Brian S. Kim unpacks the latest breakthroughs in the neuroimmunology of itch, revealing how innovative targeted treatments are transforming our approach to chronic itch and reshaping dermatologic care.
Dr Brian S. Kim unpacks the latest breakthroughs in the neuroimmunology of itch, revealing how innovative targeted treatments are transforming our approach to chronic itch and reshaping dermatologic care.
Dr Brian S. Kim unpacks the...
05/01/2025
The Dermatologist
Allergen Focus
What’s New in Allergic Contact Dermatitis? 2025’s Allergens on the Rise
05/01/2025
Braily Weber, BS, BA; Sara A. Hylwa, MD
Familiarize yourself with up-and-coming allergens, including their chemical function, role in consumer products, and reported cases of contact allergy.
Familiarize yourself with up-and-coming allergens, including their chemical function, role in consumer products, and reported cases of contact allergy.
Familiarize yourself with...
05/01/2025
The Dermatologist
NEA Approved Features
Addressing Acute Care Needs in Atopic Dermatitis: A Call for Improved Access and Management
03/06/2025
Lisa Kuhs, PhD
National Eczema Association survey examines the frequency of acute care needs among patients with atopic dermatitis and the wait times they experience when seeking care from their primary atopic dermatitis health care providers.
National Eczema Association survey examines the frequency of acute care needs among patients with atopic dermatitis and the wait times they experience when seeking care from their primary atopic dermatitis health care providers.
National Eczema Association...
03/06/2025
The Dermatologist
Clinical Insights
JAK Inhibitors in Atopic Dermatitis Treatment
03/06/2025
Riya Gandhi, MA
“As our understanding of a disease continues to evolve and get more advanced, it lets us develop therapies that are much more targeted in treating the disease,” says Dr Eingun James Song.
“As our understanding of a disease continues to evolve and get more advanced, it lets us develop therapies that are much more targeted in treating the disease,” says Dr Eingun James Song.
“As our understanding of a...
03/06/2025
The Dermatologist
NEA Approved Features
The State of AD: Why We Are Building the First Indicator Report of Its Kind
10/02/2026
Coleen Stern, MA
In this 2-part series, the National Eczema Association outlines its comprehensive State of AD Indicator Report, providing a foundation for targeted action nationwide.
In this 2-part series, the National Eczema Association outlines its comprehensive State of AD Indicator Report, providing a foundation for targeted action nationwide.
In this 2-part series, the...
10/02/2026
The Dermatologist
Cover Story
The Industry Dermatologist: Building a Career at the Intersection of Science, Innovation, and Patient Care
10/02/2026
Ayman Grada, MD, MHA; Riya Gandhi, MA
Dr Ayman Grada shares his perspective on how dermatologists can bring clinical insight and scientific expertise to biopharma while keeping patient care at the center of their work.
Dr Ayman Grada shares his perspective on how dermatologists can bring clinical insight and scientific expertise to biopharma while keeping patient care at the center of their work.
Dr Ayman Grada shares his...
10/02/2026
The Dermatologist
Cover Story
Dermatology in the Digital Age: How Technology Is Transforming Clinical Practice
09/03/2026
Daniel M. Siegel, MD, MS, FAAD, FACMS; Riya Gandhi, MA
How can clinicians harness emerging technologies to improve efficiency and patient care while navigating the challenges of privacy, regulation, medicolegal risk, and information overload?
How can clinicians harness emerging technologies to improve efficiency and patient care while navigating the challenges of privacy, regulation, medicolegal risk, and information overload?
How can clinicians harness...
09/03/2026
The Dermatologist
Feature Story
The Eye-Skin Connection: Ocular Red Flags Every Dermatologist Should Know
09/03/2026
Jennifer Cao, MD; Riya Gandhi, MA
From uveitis and ocular cicatricial pemphigoid to SJS/TEN and hydroxychloroquine toxicity, learn what to recognize to help prevent irreversible vision loss through timely referral and multidisciplinary care.
From uveitis and ocular cicatricial pemphigoid to SJS/TEN and hydroxychloroquine toxicity, learn what to recognize to help prevent irreversible vision loss through timely referral and multidisciplinary care.
From uveitis and ocular...
09/03/2026
The Dermatologist
Allergen Focus
Allergic Contact Dermatitis to Benzyl Alcohol
09/03/2026
Hani A. Abi, BA; Sara A. Hylwa, MD; Divya R. Alley, BS; Anne Neeley, MD
This case series highlights clinical patterns of the American Contact Dermatitis Society’s 2026 Allergen of the Year.
This case series highlights clinical patterns of the American Contact Dermatitis Society’s 2026 Allergen of the Year.
This case series highlights...
09/03/2026
The Dermatologist
Feature Story
Special Delivery of Topical Interest: Understanding Vehicle Formulation for Nonsteroidal Prescription Eczema Creams
08/04/2026
Julia Ross, MD; Noah A. Levit, MD, PhD, FAAD
This article examines the evolving landscape of nonsteroidal topical therapies for atopic dermatitis and chronic hand eczema, with a specific focus on how vehicle formulation and excipient selection may influence clinical performance beyond...
This article examines the evolving landscape of nonsteroidal topical therapies for atopic dermatitis and chronic hand eczema, with a specific focus on how vehicle formulation and excipient selection may influence clinical performance beyond...
This article examines the...
08/04/2026
The Dermatologist
Clinical Insights
Improving Quality of Life for Patients With Chronic Spontaneous Urticaria
08/04/2026
Mona Shahriari, MD, FAAD; Riya Gandhi, MA
Advances in our understanding of this complex inflammatory skin disorder are driving more personalized, mechanism-based treatment approaches that can help patients achieve better disease control.
Advances in our understanding of this complex inflammatory skin disorder are driving more personalized, mechanism-based treatment approaches that can help patients achieve better disease control.
Advances in our understanding of...
08/04/2026
The Dermatologist
Allergen Focus
Behind the Bubbles: A Guide to Surfactants as Potential Allergens
08/04/2026
Divya R. Alley, BS; Sara A. Hylwa, MD
This article provides an overview of the common classes of surfactants, including their functionality, routes of exposure, and cases of reported contact allergy.
This article provides an overview of the common classes of surfactants, including their functionality, routes of exposure, and cases of reported contact allergy.
This article provides an...
08/04/2026
The Dermatologist
Cover Story
Ultrasound as a Transformative Tool in Dermatology
08/04/2026
Jane Y. Yoo, MD; Riya Gandhi, MA
Dr Jane Yoo explains how this rapidly expanding technology is helping clinicians uncover hidden disease, improve treatment decisions, and reshape patient care.
Dr Jane Yoo explains how this rapidly expanding technology is helping clinicians uncover hidden disease, improve treatment decisions, and reshape patient care.
Dr Jane Yoo explains how this...
08/04/2026
The Dermatologist
Clinical Insights
Prurigo Nodularis: When Type 2 Inflammation Meets Neuronal Sensitization
06/08/2026
Raj Chovatiya, MD, PhD; Riya Gandhi, MA
Dr Raj Chovatiya explores the neuroimmune mechanisms of this chronic inflammatory disease.
Dr Raj Chovatiya explores the neuroimmune mechanisms of this chronic inflammatory disease.
Dr Raj Chovatiya explores the...
06/08/2026
The Dermatologist

Quizzes

Physician and older couple
Quiz
Which Systemic Therapy Raises Red Flags in Older Adults?
09/18/2025
Riya Gandhi, MA
Older patients need special consideration. Take the quiz to identify which systemic drug class carries higher risks—like thrombosis and malignancy—and requires extra caution in aging populations.
Older patients need special consideration. Take the quiz to identify which systemic drug class carries higher risks—like thrombosis and malignancy—and requires extra caution in aging populations.
Older patients need special...
09/18/2025
The Dermatologist
Itchy arm
Quiz
The Overlooked Allergen Missing from Most Patch Test Panels
07/25/2025
Riya Gandhi, MA
Think you’re testing for all the right allergens? Take the quiz to learn which emerging culprit in skincare often flies under the radar.
Think you’re testing for all the right allergens? Take the quiz to learn which emerging culprit in skincare often flies under the radar.
Think you’re testing for all the...
07/25/2025
The Dermatologist
Atopic dermatitis
Quiz
Tacrolimus Aggravating Symptoms? Know the Next Best Step
07/18/2025
Riya Gandhi, MA
When dermatitis worsens during topical calcineurin inhibitor therapy, what's your next move? Quiz yourself on clinical best practices in ACD evaluation.
When dermatitis worsens during topical calcineurin inhibitor therapy, what's your next move? Quiz yourself on clinical best practices in ACD evaluation.
When dermatitis worsens during...
07/18/2025
The Dermatologist
Atopic dermatitis
Quiz
The Hypoallergenic Paradox: Which Common Additive Can Trigger ACD?
07/11/2025
Riya Gandhi, MA
Test your dermatology knowledge—can you identify the allergen found in hypoallergenic products that’s increasingly associated with allergic contact dermatitis?
Test your dermatology knowledge—can you identify the allergen found in hypoallergenic products that’s increasingly associated with allergic contact dermatitis?
Test your dermatology...
07/11/2025
The Dermatologist
products
Quiz
Hair Product Allergen Exposed: What’s Causing This Dermatitis Pattern?
07/04/2025
Riya Gandhi, MA
A patient presents with scalp and upper back dermatitis after a new conditioner. Can you pinpoint the likely culprit among common hair care allergens?
A patient presents with scalp and upper back dermatitis after a new conditioner. Can you pinpoint the likely culprit among common hair care allergens?
A patient presents with scalp...
07/04/2025
The Dermatologist
Atopic dermatitis
Quiz
Targeting Itch in Atopic Dermatitis: Cytokines and Novel Therapies
05/28/2025
Riya Gandhi, MA
Challenge your dermatology expertise with this interactive quiz on cytokine-driven itch, neuroinflammation, and the latest targeted therapies like dupilumab and nemolizumab.
Challenge your dermatology expertise with this interactive quiz on cytokine-driven itch, neuroinflammation, and the latest targeted therapies like dupilumab and nemolizumab.
Challenge your dermatology...
05/28/2025
The Dermatologist
Atopic dermatitis
Quiz
Manage Acute Flares in Atopic Dermatitis
04/22/2025
Riya Gandhi, MA
Test your knowledge on managing acute flares in atopic dermatitis. Learn about eczema action plans, proactive care models, and key patient education strategies to improve outcomes.
Test your knowledge on managing acute flares in atopic dermatitis. Learn about eczema action plans, proactive care models, and key patient education strategies to improve outcomes.
Test your knowledge on managing...
04/22/2025
The Dermatologist
Physician talking with patient
Quiz
Patient-Provider Alignment on AD Flare
03/25/2025
Riya Gandhi, MA
Explore how patients and providers can align on defining atopic dermatitis (AD) flares to improve communication, treatment decisions, and shared decision-making. Take this interactive quiz to test your knowledge and learn how patient-centered...
Explore how patients and providers can align on defining atopic dermatitis (AD) flares to improve communication, treatment decisions, and shared decision-making. Take this interactive quiz to test your knowledge and learn how patient-centered...
Explore how patients and...
03/25/2025
The Dermatologist
Atopic Dermatitis + Eczema_2.jpg
Quiz
Key Parts of The Flare Experience
03/16/2025
Riya Gandhi, MA
How well do you understand the patient perspective on atopic dermatitis flares? Take this quiz to explore key patient-described flare indicators, emotional and social impacts, and insights from NEA research.
How well do you understand the patient perspective on atopic dermatitis flares? Take this quiz to explore key patient-described flare indicators, emotional and social impacts, and insights from NEA research.
How well do you understand the...
03/16/2025
The Dermatologist
Atopic dermatitis
Quiz
Indicators of an AD Flare
03/11/2025
Riya Gandhi, MA
Test your knowledge of how patients with atopic dermatitis (AD) define and experience flares. This quiz highlights key indicators, patient-described attributes, and insights from the NEA’s research into AD flare triggers and symptoms.
Test your knowledge of how patients with atopic dermatitis (AD) define and experience flares. This quiz highlights key indicators, patient-described attributes, and insights from the NEA’s research into AD flare triggers and symptoms.
Test your knowledge of how...
03/11/2025
The Dermatologist
Physician with child
Quiz
Pediatric Patients With Atopic Dermatitis Receiving Dupilumab
11/03/2026
Jessica Garlewicz
What proportion of children aged 6 to 11 years with severe atopic dermatitis receiving dupilumab achieved a height increase of at least 5 percentile points after 4 months of treatment?
What proportion of children aged 6 to 11 years with severe atopic dermatitis receiving dupilumab achieved a height increase of at least 5 percentile points after 4 months of treatment?
What proportion of children aged...
11/03/2026
The Dermatologist
magnifying glass in front of stacks of books
Quiz
Therapeutic Response Heterogeneity and Precision Medicine in Type 2 Inflammation
11/02/2026
Riya Gandhi, MA
Evaluate advanced clinical reasoning in targeted treatment selection, unexpected therapeutic responses, and the challenges of precision medicine in inflammatory dermatology.
Evaluate advanced clinical reasoning in targeted treatment selection, unexpected therapeutic responses, and the challenges of precision medicine in inflammatory dermatology.
Evaluate advanced clinical...
11/02/2026
The Dermatologist
Illustration-depicting-knowledge-or-education
Quiz
Neuroimmune Interactions and Disease Persistence in Type 2 Inflammation
11/02/2026
Riya Gandhi, MA
Challenge your understanding of inflammatory feedback mechanisms, neuronal sensitization, and the complex cellular interactions involved in chronic dermatologic disease.
Challenge your understanding of inflammatory feedback mechanisms, neuronal sensitization, and the complex cellular interactions involved in chronic dermatologic disease.
Challenge your understanding of...
11/02/2026
The Dermatologist
Clock for test
Quiz
Understanding Type 2 Inflammation Across Inflammatory Skin Diseases
11/02/2026
Riya Gandhi, MA
Test your clinical understanding of inflammatory disease classification, overlapping immune pathways, and the evolving role of type 2 inflammation in dermatology.
Test your clinical understanding of inflammatory disease classification, overlapping immune pathways, and the evolving role of type 2 inflammation in dermatology.
Test your clinical understanding...
11/02/2026
The Dermatologist
Book with arrows
Quiz
Advanced Therapeutic Sequencing and Personalized Care in Type 2 Inflammatory Skin Disease
10/25/2026
Riya Gandhi, MA
Challenge your understanding of treatment sequencing, biologic failure, JAK inhibitor escalation, and future biomarker-driven approaches in inflammatory dermatology.
Challenge your understanding of treatment sequencing, biologic failure, JAK inhibitor escalation, and future biomarker-driven approaches in inflammatory dermatology.
Challenge your understanding of...
10/25/2026
The Dermatologist
AD
Quiz
Precision Therapeutic Selection Across Type 2 Inflammatory Skin Diseases
10/15/2026
Riya Gandhi, MA
Evaluate your clinical approach to selecting targeted therapies across multiple type 2 inflammatory skin diseases by integrating disease biology, symptom burden, and treatment sequencing.
Evaluate your clinical approach to selecting targeted therapies across multiple type 2 inflammatory skin diseases by integrating disease biology, symptom burden, and treatment sequencing.
Evaluate your clinical approach...
10/15/2026
The Dermatologist
HS
Quiz
Quiz: Efficacy Findings for Povorcitinib in the Phase 3 STOP-HS1 and STOP-HS2 Trials
10/01/2026
Jessica Garlewicz
Which of the following best describes the week 12 efficacy findings for povorcitinib in the phase 3 STOP-HS1 and STOP-HS2 trials in patients with moderate-to-severe hidradenitis suppurativa?
Which of the following best describes the week 12 efficacy findings for povorcitinib in the phase 3 STOP-HS1 and STOP-HS2 trials in patients with moderate-to-severe hidradenitis suppurativa?
Which of the following best...
10/01/2026
The Dermatologist
itch
Quiz
Clinical Implications of Type 2 Inflammation in Chronic Spontaneous Urticaria
09/21/2026
Riya Gandhi, MA
Evaluate your understanding of disease fluctuation, neuroimmune signaling, cytokine biology, and targeted therapeutic strategies in chronic spontaneous urticaria.
Evaluate your understanding of disease fluctuation, neuroimmune signaling, cytokine biology, and targeted therapeutic strategies in chronic spontaneous urticaria.
Evaluate your understanding of...
09/21/2026
The Dermatologist
random molecule
Quiz
Understanding Type 2 Inflammatory Mechanisms in Chronic Spontaneous Urticaria
09/14/2026
Riya Gandhi, MA
Test your understanding of cytokine signaling, mast cell biology, neuroimmune interactions, and the mechanisms that drive chronic spontaneous urticaria.
Test your understanding of cytokine signaling, mast cell biology, neuroimmune interactions, and the mechanisms that drive chronic spontaneous urticaria.
Test your understanding of...
09/14/2026
The Dermatologist
AD
Quiz
Pediatric AD Quiz: Biologic Therapy Challenges in Children
08/10/2026
Riya Gandhi, MA
Assess your understanding of biologic therapy in pediatric atopic dermatitis with this expert quiz. Explore practical barriers to treatment, considerations for young children and caregivers, and real-world factors that influence successful...
Assess your understanding of biologic therapy in pediatric atopic dermatitis with this expert quiz. Explore practical barriers to treatment, considerations for young children and caregivers, and real-world factors that influence successful...
Assess your understanding of...
08/10/2026
The Dermatologist

Conference Coverage

Baldwin
Videos
The Skin Microbiome: Dermatologic Insights
05/22/2026
Hilary E. Baldwin, MD; Riya Gandhi, MA
Dr Hilary Baldwin discusses how evolving insights into the skin microbiome are reshaping the understanding of acne, eczema, rosacea, and other inflammatory skin diseases.
Dr Hilary Baldwin discusses how evolving insights into the skin microbiome are reshaping the understanding of acne, eczema, rosacea, and other inflammatory skin diseases.
Dr Hilary Baldwin discusses how...
05/22/2026
The Dermatologist
Dr Guttman
Conference Coverage
Atopic Dermatitis: OX40, IL-31, Treg Therapy, and the JAK Head-to-Head Era
02/21/2026
Riya Gandhi, MA
A dermatology update on atopic dermatitis therapeutics, highlighting dupilumab, lebrikizumab, nemolizumab, rocatinlimab (OX40), amlitelimab (OX40L), rezpegaldesleukin, and oral JAK inhibitors (upadacitinib, abrocitinib).
A dermatology update on atopic dermatitis therapeutics, highlighting dupilumab, lebrikizumab, nemolizumab, rocatinlimab (OX40), amlitelimab (OX40L), rezpegaldesleukin, and oral JAK inhibitors (upadacitinib, abrocitinib).
A dermatology update on atopic...
02/21/2026
The Dermatologist
Dr Guttman
Conference Coverage
Chronic Hand Eczema: From Pathogenic Subtypes to Targeted JAK and IL-4/13 Therapy
02/20/2026
Riya Gandhi, MA
A clinical update on chronic hand eczema, highlighting delgocitinib cream, ruxolitinib, gusacitinib, dupilumab, tralokinumab, and biomarker-driven Th1/Th2/Th17 endotypes.
A clinical update on chronic hand eczema, highlighting delgocitinib cream, ruxolitinib, gusacitinib, dupilumab, tralokinumab, and biomarker-driven Th1/Th2/Th17 endotypes.
A clinical update on chronic...
02/20/2026
The Dermatologist
Mona Shahriari, MD, FAAD
Conference Coverage
Clarifying the Role of IL-13 Inhibitors in Atopic Dermatitis: Clinical Profiles, Comparisons, and Real-World Application
11/26/2025
Jessica Garlewicz
The session emphasized mechanism-driven selection, real-world application, and a comparison of pivotal efficacy data for the 3 IL-13–related biologics currently available: dupilumab, lebrikizumab, and tralokinumab.
The session emphasized mechanism-driven selection, real-world application, and a comparison of pivotal efficacy data for the 3 IL-13–related biologics currently available: dupilumab, lebrikizumab, and tralokinumab.
The session emphasized...
11/26/2025
The Dermatologist
Linda F. Stein Gold, MD
Conference Coverage
Charting a Path to Higher Treatment Targets With JAK Inhibition in Atopic Dermatitis
11/01/2025
Jessica Garlewicz
The session focused on elevating therapeutic expectations in AD care, analyzing data on existing JAK inhibitors, and encouraging dermatologists to challenge treatment inertia.
The session focused on elevating therapeutic expectations in AD care, analyzing data on existing JAK inhibitors, and encouraging dermatologists to challenge treatment inertia.
The session focused on elevating...
11/01/2025
The Dermatologist
lisa swanson
Conference Coverage
Breakthroughs in Pediatric Atopic Dermatitis Care
05/16/2025
Riya Gandhi, MA
Lisa Swanson, MD, delivered an engaging overview of evolving treatment strategies for childhood atopic dermatitis—spotlighting new nonsteroidal topicals, simplified routines, and language that resonates with families.
Lisa Swanson, MD, delivered an engaging overview of evolving treatment strategies for childhood atopic dermatitis—spotlighting new nonsteroidal topicals, simplified routines, and language that resonates with families.
Lisa Swanson, MD, delivered an...
05/16/2025
The Dermatologist
Peter Lio
Conference Coverage
Environmental Factors Play a Major Role in Atopic Dermatitis
05/16/2025
Riya Gandhi, MA
Dr Peter Lio explained how pollution, modern lifestyle, and even hygiene products are damaging the skin barrier and fueling the rise in atopic diseases like eczema.
Dr Peter Lio explained how pollution, modern lifestyle, and even hygiene products are damaging the skin barrier and fueling the rise in atopic diseases like eczema.
Dr Peter Lio explained how...
05/16/2025
The Dermatologist
merola
Conference Coverage
The Impact of Topical PDE-4 Inhibitors in Atopic Dermatitis, Seborrheic Dermatitis, and Psoriasis
05/08/2024
Riya Gandhi, MA
During his session at Spring Dermatology Week 2024, Dr Joseph Merola illuminated the potential of topical phosphodiesterase-4 inhibitors in the management of atopic dermatitis, seborrheic dermatitis, and psoriasis.
During his session at Spring Dermatology Week 2024, Dr Joseph Merola illuminated the potential of topical phosphodiesterase-4 inhibitors in the management of atopic dermatitis, seborrheic dermatitis, and psoriasis.
During his session at Spring...
05/08/2024
The Dermatologist
Raj Chovatiya, MD, PhD
Conference Coverage
Individualizing Biologic Therapy for Atopic Dermatitis
10/09/2026
Jessica Garlewicz
Ahead of his session at the 2026 Fall Clinical Dermatology Conference, Raj Chovatiya, MD, PhD, discussed key considerations for individualizing biologic therapy in moderate-to-severe AD.
Ahead of his session at the 2026 Fall Clinical Dermatology Conference, Raj Chovatiya, MD, PhD, discussed key considerations for individualizing biologic therapy in moderate-to-severe AD.
Ahead of his session at the 2026...
10/09/2026
The Dermatologist
Lisa Swanson
Conference Coverage
Expert Insights: Biologic Decision-Making for Moderate-to-Severe Atopic Dermatitis
10/09/2026
Jessica Garlewicz
Prior to the 2026 Fall Clinical Dermatology Conference, Lisa Swanson, MD, emphasized that decisions to escalate treatment for moderate-to-severe atopic dermatitis should consider both clinical disease severity and the patient’s experience.
Prior to the 2026 Fall Clinical Dermatology Conference, Lisa Swanson, MD, emphasized that decisions to escalate treatment for moderate-to-severe atopic dermatitis should consider both clinical disease severity and the patient’s experience.
Prior to the 2026 Fall Clinical...
10/09/2026
The Dermatologist
Lain
Videos
Rosacea and Gut Health: Exploring the Gut-Skin Connection
05/27/2026
Ted Lain, MD; Riya Gandhi, MA
Dr Ted Lain discusses the emerging role of gut health in rosacea, including the link between small intestinal bacterial overgrowth (SIBO) and treatment-resistant disease.
Dr Ted Lain discusses the emerging role of gut health in rosacea, including the link between small intestinal bacterial overgrowth (SIBO) and treatment-resistant disease.
Dr Ted Lain discusses the...
05/27/2026
The Dermatologist
Baldwin
Videos
The Skin Microbiome: Dermatologic Insights
05/22/2026
Hilary E. Baldwin, MD; Riya Gandhi, MA
Dr Hilary Baldwin discusses how evolving insights into the skin microbiome are reshaping the understanding of acne, eczema, rosacea, and other inflammatory skin diseases.
Dr Hilary Baldwin discusses how evolving insights into the skin microbiome are reshaping the understanding of acne, eczema, rosacea, and other inflammatory skin diseases.
Dr Hilary Baldwin discusses how...
05/22/2026
The Dermatologist
clark
Videos
Insights Into Energy-Based Devices
05/22/2026
Patrick J. Clark, PhD; Riya Gandhi, MA
Patrick Clark, PhD, CMLSO, reviews the foundational principles behind safe and effective use of energy-based devices in dermatology, including wavelength, pulse duration, power, spot size, and target chromophore selection.
Patrick Clark, PhD, CMLSO, reviews the foundational principles behind safe and effective use of energy-based devices in dermatology, including wavelength, pulse duration, power, spot size, and target chromophore selection.
Patrick Clark, PhD, CMLSO,...
05/22/2026
The Dermatologist
Mesinkovska
Videos
Metformin, GLP-1 Agonists, and Skin Longevity: Emerging Dermatologic Insights
05/20/2026
Natasha Atanaskova Mesinkovska, MD, PhD; Riya Gandhi, MA
Dr Natasha Mesinkovska explores how metformin and GLP-1 receptor agonists may influence skin aging, pigmentation, wound healing, and longevity pathways.
Dr Natasha Mesinkovska explores how metformin and GLP-1 receptor agonists may influence skin aging, pigmentation, wound healing, and longevity pathways.
Dr Natasha Mesinkovska explores...
05/20/2026
The Dermatologist
Kaufmann
Conference Coverage
Buy-and-Bill Model May Improve Access and Practice Control in Dermatology
05/20/2026
Jessica Garlewicz
The buy-and-bill reimbursement model may provide dermatology practices with greater control over treatment delivery, faster patient access to therapy, and potential operational advantages.
The buy-and-bill reimbursement model may provide dermatology practices with greater control over treatment delivery, faster patient access to therapy, and potential operational advantages.
The buy-and-bill reimbursement...
05/20/2026
The Dermatologist
Shamban
Conference Coverage
Operational Flexibility and Layered Care Strategies Drive Practice Resilience in Dermatology
05/20/2026
Jessica Garlewicz
Scalable systems, proactive patient engagement, and integrated treatment strategies may strengthen both clinical outcomes and operational resilience in dermatology practices.
Scalable systems, proactive patient engagement, and integrated treatment strategies may strengthen both clinical outcomes and operational resilience in dermatology practices.
Scalable systems, proactive...
05/20/2026
The Dermatologist
Marmur
Conference Coverage
Strategic Planning and Team Alignment Are Central to Successful Practice Sales
05/20/2026
Jessica Garlewicz
Selling a dermatology practice requires long-term planning, financial analysis, and careful alignment between physicians, staff, and investors.
Selling a dermatology practice requires long-term planning, financial analysis, and careful alignment between physicians, staff, and investors.
Selling a dermatology practice...
05/20/2026
The Dermatologist
Allen
Videos
Multimodal Biostimulation in Dermatology: PDGF-BB, Hyperdilute CaHA, and Microneedling
05/20/2026
Sarah L. Allen, MD; Riya Gandhi, MA
Dr Sarah Allen discusses the science behind combining PDGF-BB, hyperdilute calcium hydroxylapatite, and microneedling to improve cellulite, striae, and skin laxity through regenerative biostimulation.
Dr Sarah Allen discusses the science behind combining PDGF-BB, hyperdilute calcium hydroxylapatite, and microneedling to improve cellulite, striae, and skin laxity through regenerative biostimulation.
Dr Sarah Allen discusses the...
05/20/2026
The Dermatologist

Popular Articles

Depressed-woman-sitting-on-edge-of-bed
Quiz
Acne and Depressive Symptoms
02/07/2025
In a comparison of the mental health of patients with acne treated with isotretinoin vs oral antibiotics, which treatment group was found to experience more depressive symptoms and psychological distress?
In a comparison of the mental health of patients with acne treated with isotretinoin vs oral antibiotics, which treatment group was found to experience more depressive symptoms and psychological distress?
In a comparison of the mental...
02/07/2025
The Dermatologist
Jeffrey M. Cohen, MD
Conference Coverage
TYK2 as a Therapeutic Target in Psoriasis
08/11/2025
Coleen Stern, MA
Jeffrey M. Cohen, MD, discussed TYK2 inhibitors, a new class of therapy being studied for the treatment of psoriasis.
Jeffrey M. Cohen, MD, discussed TYK2 inhibitors, a new class of therapy being studied for the treatment of psoriasis.
Jeffrey M. Cohen, MD, discussed...
08/11/2025
The Dermatologist
Dr Adam Friedman
Podcasts
The Real Derm: Episode 5, Diving Deep Into the DermPath Pathway: A Candidate's Perspective
07/10/2025
Adam Friedman, MD
Climbing the mountain to get to dermatology residency is bone breaking enough, but what about the next apex, even more specialized training such as a Dermatopathology Fellowship?
Climbing the mountain to get to dermatology residency is bone breaking enough, but what about the next apex, even more specialized training such as a Dermatopathology Fellowship?
Climbing the mountain to get to...
07/10/2025
The Dermatologist
Atopic dermatitis
Quiz
Pediatric Atopic Dermatitis Management
11/11/2024
Riya Gandhi, MA
What alternative therapies does Dr Lisa Swanson suggest for children who have difficulty adhering to topical treatment regimens?
What alternative therapies does Dr Lisa Swanson suggest for children who have difficulty adhering to topical treatment regimens?
What alternative therapies does...
11/11/2024
The Dermatologist
NAAF-Reviewed Content
Managing Pediatric Alopecia Areata: Part 1
12/02/2024
Riya Gandhi, MA
Alopecia areata is one of the most common hair loss disorders seen in children presenting with hair loss.
Alopecia areata is one of the most common hair loss disorders seen in children presenting with hair loss.
Alopecia areata is one of the...
12/02/2024
The Dermatologist
october 2026

Current Issue

October 2026
Volume 34
Issue 7
Current Issue
Issue Archive

Latest Quizzes

Physician and older couple
Quiz
Which Systemic Therapy Raises Red Flags in Older Adults?
09/18/2025
Riya Gandhi, MA
Older patients need special consideration. Take the quiz to identify which systemic drug class carries higher risks—like thrombosis and malignancy—and requires extra caution in aging populations.
Older patients need special consideration. Take the quiz to identify which systemic drug class carries higher risks—like thrombosis and malignancy—and requires extra caution in aging populations.
Older patients need special...
09/18/2025
The Dermatologist
Itchy arm
Quiz
The Overlooked Allergen Missing from Most Patch Test Panels
07/25/2025
Riya Gandhi, MA
Think you’re testing for all the right allergens? Take the quiz to learn which emerging culprit in skincare often flies under the radar.
Think you’re testing for all the right allergens? Take the quiz to learn which emerging culprit in skincare often flies under the radar.
Think you’re testing for all the...
07/25/2025
The Dermatologist
Atopic dermatitis
Quiz
Tacrolimus Aggravating Symptoms? Know the Next Best Step
07/18/2025
Riya Gandhi, MA
When dermatitis worsens during topical calcineurin inhibitor therapy, what's your next move? Quiz yourself on clinical best practices in ACD evaluation.
When dermatitis worsens during topical calcineurin inhibitor therapy, what's your next move? Quiz yourself on clinical best practices in ACD evaluation.
When dermatitis worsens during...
07/18/2025
The Dermatologist
Atopic dermatitis
Quiz
The Hypoallergenic Paradox: Which Common Additive Can Trigger ACD?
07/11/2025
Riya Gandhi, MA
Test your dermatology knowledge—can you identify the allergen found in hypoallergenic products that’s increasingly associated with allergic contact dermatitis?
Test your dermatology knowledge—can you identify the allergen found in hypoallergenic products that’s increasingly associated with allergic contact dermatitis?
Test your dermatology...
07/11/2025
The Dermatologist
products
Quiz
Hair Product Allergen Exposed: What’s Causing This Dermatitis Pattern?
07/04/2025
Riya Gandhi, MA
A patient presents with scalp and upper back dermatitis after a new conditioner. Can you pinpoint the likely culprit among common hair care allergens?
A patient presents with scalp and upper back dermatitis after a new conditioner. Can you pinpoint the likely culprit among common hair care allergens?
A patient presents with scalp...
07/04/2025
The Dermatologist
Atopic dermatitis
Quiz
Targeting Itch in Atopic Dermatitis: Cytokines and Novel Therapies
05/28/2025
Riya Gandhi, MA
Challenge your dermatology expertise with this interactive quiz on cytokine-driven itch, neuroinflammation, and the latest targeted therapies like dupilumab and nemolizumab.
Challenge your dermatology expertise with this interactive quiz on cytokine-driven itch, neuroinflammation, and the latest targeted therapies like dupilumab and nemolizumab.
Challenge your dermatology...
05/28/2025
The Dermatologist
Atopic dermatitis
Quiz
Manage Acute Flares in Atopic Dermatitis
04/22/2025
Riya Gandhi, MA
Test your knowledge on managing acute flares in atopic dermatitis. Learn about eczema action plans, proactive care models, and key patient education strategies to improve outcomes.
Test your knowledge on managing acute flares in atopic dermatitis. Learn about eczema action plans, proactive care models, and key patient education strategies to improve outcomes.
Test your knowledge on managing...
04/22/2025
The Dermatologist
Physician talking with patient
Quiz
Patient-Provider Alignment on AD Flare
03/25/2025
Riya Gandhi, MA
Explore how patients and providers can align on defining atopic dermatitis (AD) flares to improve communication, treatment decisions, and shared decision-making. Take this interactive quiz to test your knowledge and learn how patient-centered...
Explore how patients and providers can align on defining atopic dermatitis (AD) flares to improve communication, treatment decisions, and shared decision-making. Take this interactive quiz to test your knowledge and learn how patient-centered...
Explore how patients and...
03/25/2025
The Dermatologist
Atopic Dermatitis + Eczema_2.jpg
Quiz
Key Parts of The Flare Experience
03/16/2025
Riya Gandhi, MA
How well do you understand the patient perspective on atopic dermatitis flares? Take this quiz to explore key patient-described flare indicators, emotional and social impacts, and insights from NEA research.
How well do you understand the patient perspective on atopic dermatitis flares? Take this quiz to explore key patient-described flare indicators, emotional and social impacts, and insights from NEA research.
How well do you understand the...
03/16/2025
The Dermatologist
Atopic dermatitis
Quiz
Indicators of an AD Flare
03/11/2025
Riya Gandhi, MA
Test your knowledge of how patients with atopic dermatitis (AD) define and experience flares. This quiz highlights key indicators, patient-described attributes, and insights from the NEA’s research into AD flare triggers and symptoms.
Test your knowledge of how patients with atopic dermatitis (AD) define and experience flares. This quiz highlights key indicators, patient-described attributes, and insights from the NEA’s research into AD flare triggers and symptoms.
Test your knowledge of how...
03/11/2025
The Dermatologist
Physician with child
Quiz
Pediatric Patients With Atopic Dermatitis Receiving Dupilumab
11/03/2026
Jessica Garlewicz
What proportion of children aged 6 to 11 years with severe atopic dermatitis receiving dupilumab achieved a height increase of at least 5 percentile points after 4 months of treatment?
What proportion of children aged 6 to 11 years with severe atopic dermatitis receiving dupilumab achieved a height increase of at least 5 percentile points after 4 months of treatment?
What proportion of children aged...
11/03/2026
The Dermatologist
magnifying glass in front of stacks of books
Quiz
Therapeutic Response Heterogeneity and Precision Medicine in Type 2 Inflammation
11/02/2026
Riya Gandhi, MA
Evaluate advanced clinical reasoning in targeted treatment selection, unexpected therapeutic responses, and the challenges of precision medicine in inflammatory dermatology.
Evaluate advanced clinical reasoning in targeted treatment selection, unexpected therapeutic responses, and the challenges of precision medicine in inflammatory dermatology.
Evaluate advanced clinical...
11/02/2026
The Dermatologist
Illustration-depicting-knowledge-or-education
Quiz
Neuroimmune Interactions and Disease Persistence in Type 2 Inflammation
11/02/2026
Riya Gandhi, MA
Challenge your understanding of inflammatory feedback mechanisms, neuronal sensitization, and the complex cellular interactions involved in chronic dermatologic disease.
Challenge your understanding of inflammatory feedback mechanisms, neuronal sensitization, and the complex cellular interactions involved in chronic dermatologic disease.
Challenge your understanding of...
11/02/2026
The Dermatologist
Clock for test
Quiz
Understanding Type 2 Inflammation Across Inflammatory Skin Diseases
11/02/2026
Riya Gandhi, MA
Test your clinical understanding of inflammatory disease classification, overlapping immune pathways, and the evolving role of type 2 inflammation in dermatology.
Test your clinical understanding of inflammatory disease classification, overlapping immune pathways, and the evolving role of type 2 inflammation in dermatology.
Test your clinical understanding...
11/02/2026
The Dermatologist
Book with arrows
Quiz
Advanced Therapeutic Sequencing and Personalized Care in Type 2 Inflammatory Skin Disease
10/25/2026
Riya Gandhi, MA
Challenge your understanding of treatment sequencing, biologic failure, JAK inhibitor escalation, and future biomarker-driven approaches in inflammatory dermatology.
Challenge your understanding of treatment sequencing, biologic failure, JAK inhibitor escalation, and future biomarker-driven approaches in inflammatory dermatology.
Challenge your understanding of...
10/25/2026
The Dermatologist
AD
Quiz
Precision Therapeutic Selection Across Type 2 Inflammatory Skin Diseases
10/15/2026
Riya Gandhi, MA
Evaluate your clinical approach to selecting targeted therapies across multiple type 2 inflammatory skin diseases by integrating disease biology, symptom burden, and treatment sequencing.
Evaluate your clinical approach to selecting targeted therapies across multiple type 2 inflammatory skin diseases by integrating disease biology, symptom burden, and treatment sequencing.
Evaluate your clinical approach...
10/15/2026
The Dermatologist
HS
Quiz
Quiz: Efficacy Findings for Povorcitinib in the Phase 3 STOP-HS1 and STOP-HS2 Trials
10/01/2026
Jessica Garlewicz
Which of the following best describes the week 12 efficacy findings for povorcitinib in the phase 3 STOP-HS1 and STOP-HS2 trials in patients with moderate-to-severe hidradenitis suppurativa?
Which of the following best describes the week 12 efficacy findings for povorcitinib in the phase 3 STOP-HS1 and STOP-HS2 trials in patients with moderate-to-severe hidradenitis suppurativa?
Which of the following best...
10/01/2026
The Dermatologist
itch
Quiz
Clinical Implications of Type 2 Inflammation in Chronic Spontaneous Urticaria
09/21/2026
Riya Gandhi, MA
Evaluate your understanding of disease fluctuation, neuroimmune signaling, cytokine biology, and targeted therapeutic strategies in chronic spontaneous urticaria.
Evaluate your understanding of disease fluctuation, neuroimmune signaling, cytokine biology, and targeted therapeutic strategies in chronic spontaneous urticaria.
Evaluate your understanding of...
09/21/2026
The Dermatologist
random molecule
Quiz
Understanding Type 2 Inflammatory Mechanisms in Chronic Spontaneous Urticaria
09/14/2026
Riya Gandhi, MA
Test your understanding of cytokine signaling, mast cell biology, neuroimmune interactions, and the mechanisms that drive chronic spontaneous urticaria.
Test your understanding of cytokine signaling, mast cell biology, neuroimmune interactions, and the mechanisms that drive chronic spontaneous urticaria.
Test your understanding of...
09/14/2026
The Dermatologist
AD
Quiz
Pediatric AD Quiz: Biologic Therapy Challenges in Children
08/10/2026
Riya Gandhi, MA
Assess your understanding of biologic therapy in pediatric atopic dermatitis with this expert quiz. Explore practical barriers to treatment, considerations for young children and caregivers, and real-world factors that influence successful...
Assess your understanding of biologic therapy in pediatric atopic dermatitis with this expert quiz. Explore practical barriers to treatment, considerations for young children and caregivers, and real-world factors that influence successful...
Assess your understanding of...
08/10/2026
The Dermatologist

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use